Kaushik Banerjee Selected Research

Ligands

1/2022	Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
12/2016	A copper chelate induces apoptosis and overcomes multidrug resistance in T-cell acute lymphoblastic leukemia through redox imbalance and inhibition of EGFR/PI3K/Akt expression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaushik Banerjee Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 05/2011
10	Ascites 10/2021 - 09/2011
10	Carcinoma (Carcinomatosis) 10/2021 - 09/2011
8	Glioma (Gliomas) 03/2024 - 01/2021
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2016 - 05/2011
3	Poliomyelitis (Polio) 04/2003 - 01/2002
2	Brain Neoplasms (Brain Tumor) 06/2023 - 01/2021
2	Leukemia 12/2016 - 02/2014
1	Metabolic Diseases (Metabolic Disease) 12/2023
1	Inflammation (Inflammations) 01/2023
1	Rheumatic Diseases (Rheumatism) 01/2023
1	Bites and Stings (Sting) 11/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Mycoses (Diseases, Fungus) 11/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Breast Neoplasms (Breast Cancer) 03/2017
1	Malaria 01/2017
1	Measles 01/2017
1	Melanoma (Melanoma, Malignant) 01/2017
1	Dehydration (Water Stress) 01/2017
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Adenocarcinoma of Lung 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 12/2016
1	Bacterial Infections (Bacterial Infection) 09/2013
1	Necrosis 01/2012
1	Paralysis (Palsy) 01/2002

Drug/Important Bio-Agent (IBA)

9	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 09/2011
6	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 12/2017 - 05/2011
5	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2011
5	Schiff Bases (Schiff Base)IBA 12/2017 - 01/2014
5	Glutathione (Reduced Glutathione)IBA 03/2017 - 01/2012
5	CopperIBA 12/2016 - 05/2011
3	Antineoplastic Agents (Antineoplastics)IBA 12/2017 - 08/2017
3	Annexin A5IBA 01/2017 - 06/2013
3	VaccinesIBA 01/2017 - 01/2002
2	RNA (Ribonucleic Acid)IBA 03/2024 - 06/2023
2	Small Interfering RNA (siRNA)IBA 03/2024 - 01/2023
2	Histones (Histone)IBA 06/2023 - 01/2021
2	CytokinesIBA 11/2022 - 01/2021
2	LigandsIBA 01/2022 - 12/2016
2	Hydroxamic Acids (Hydroxamic Acid)IBA 10/2021 - 02/2014
2	ZincIBA 12/2017 - 11/2011
2	ManganeseIBA 03/2017 - 07/2013
2	Methylnitronitrosoguanidine (MNNG)IBA 03/2017 - 07/2013
2	catalase-polyethylene glycolIBA 12/2016 - 01/2012
2	MetalsIBA 01/2014 - 11/2011
2	multidrug resistance-associated protein 1IBA 02/2012 - 01/2012
1	Endocrine DisruptorsIBA 12/2023
1	Grape Seed ExtractIBA 01/2023
1	AGI-5198IBA 01/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023
1	ChromatinIBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	ChemokinesIBA 01/2022
1	antiglomerular basement membrane antibodyIBA 01/2022
1	diphenyl (biphenyl)IBA 10/2021
1	TinIBA 10/2021
1	oxalyl bis(N-phenyl)hydroxamic acidIBA 10/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	epidermal growth factor receptor VIIIIBA 01/2021
1	ProdrugsIBA 01/2021
1	MycotoxinsIBA 11/2019
1	AntioxidantsIBA 01/2019
1	GoldIBA 01/2019
1	ElementsIBA 12/2017
1	Cysteine (L-Cysteine)FDA Link 12/2017
1	NickelIBA 12/2017
1	VanadiumIBA 08/2017
1	Vanadates (Orthovanadate)IBA 08/2017
1	CaspasesIBA 08/2017
1	AntigensIBA 01/2017
1	Immunologic Factors (Immunomodulators)IBA 09/2014
1	beta-(5-hydroxy-2-pyridyl)alanineIBA 01/2014
1	Phosphotransferases (Kinase)IBA 01/2014
1	Alanine (L-Alanine)FDA Link 01/2014
1	cupric chloride (copper(II) chloride)FDA Link 01/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2013
1	Caspase 3 (Caspase-3)IBA 06/2013
1	acetophenoneIBA 06/2013
1	IronIBA 02/2012
1	quinolineIBA 09/2011

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 12/2017 - 11/2011
4	Therapeutics 01/2023 - 09/2014
4	Immunotherapy 01/2022 - 01/2021
2	Radiotherapy 01/2023 - 01/2022
1	Chemoprevention 12/2017
1	Fluid Therapy (Oral Rehydration Therapy) 01/2017
1	Injections 04/2003